These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20648626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.
    Braconi D, Laschi M, Amato L, Bernardini G, Millucci L, Marcolongo R, Cavallo G, Spreafico A, Santucci A.
    Rheumatology (Oxford); 2010 Oct; 49(10):1975-83. PubMed ID: 20601653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
    Tinti L, Taylor AM, Santucci A, Wlodarski B, Wilson PJ, Jarvis JC, Fraser WD, Davidson JS, Ranganath LR, Gallagher JA.
    Rheumatology (Oxford); 2011 Feb; 50(2):271-7. PubMed ID: 20952450
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ, Keenan CM, Sutherland H, Wilson PJ, Wlodarski B, Taylor AM, Williams DP, Ranganath LR, Gallagher JA, Jarvis JC.
    Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
    [Abstract] [Full Text] [Related]

  • 8. Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes.
    Braconi D, Laschi M, Taylor AM, Bernardini G, Spreafico A, Tinti L, Gallagher JA, Santucci A.
    J Cell Biochem; 2010 Nov 01; 111(4):922-32. PubMed ID: 20665660
    [Abstract] [Full Text] [Related]

  • 9. Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria.
    Thorpe SD, Gambassi S, Thompson CL, Chandrakumar C, Santucci A, Knight MM.
    J Cell Physiol; 2017 Sep 01; 232(9):2407-2417. PubMed ID: 28158906
    [Abstract] [Full Text] [Related]

  • 10. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A, Petricci E, Atrei A, Baratto MC, Manetti F, Santucci A.
    Sci Rep; 2021 Nov 19; 11(1):22562. PubMed ID: 34799606
    [Abstract] [Full Text] [Related]

  • 11. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L, Spreafico A, Tinti L, Braconi D, Ghezzi L, Paccagnini E, Bernardini G, Amato L, Laschi M, Selvi E, Galeazzi M, Mannoni A, Benucci M, Lupetti P, Chellini F, Orlandini M, Santucci A.
    Biochim Biophys Acta; 2012 Nov 19; 1822(11):1682-91. PubMed ID: 22850426
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
    Hughes JH, Liu K, Plagge A, Wilson PJM, Sutherland H, Norman BP, Hughes AT, Keenan CM, Milan AM, Sakai T, Ranganath LR, Gallagher JA, Bou-Gharios G.
    Hum Mol Genet; 2019 Dec 01; 28(23):3928-3939. PubMed ID: 31600782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D, Bianchini C, Bernardini G, Laschi M, Millucci L, Spreafico A, Santucci A.
    J Inherit Metab Dis; 2011 Dec 01; 34(6):1163-76. PubMed ID: 21874298
    [Abstract] [Full Text] [Related]

  • 17. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR, Khedr M, Milan AM, Davison AS, Hughes AT, Usher JL, Taylor S, Loftus N, Daroszewska A, West E, Jones A, Briggs M, Fisher M, McCormick M, Judd S, Vinjamuri S, Griffin R, Psarelli EE, Cox TF, Sireau N, Dillon JP, Devine JM, Hughes G, Harrold J, Barton GJ, Jarvis JC, Gallagher JA.
    Mol Genet Metab; 2018 Sep 01; 125(1-2):127-134. PubMed ID: 30055994
    [Abstract] [Full Text] [Related]

  • 18. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
    Bernardini G, Laschi M, Geminiani M, Braconi D, Vannuccini E, Lupetti P, Manetti F, Millucci L, Santucci A.
    J Inherit Metab Dis; 2015 Sep 01; 38(5):807-14. PubMed ID: 25762405
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.